Extracellular Vesicles Shed by Glioma Cells: Pathogenic Role and Clinical Value

Overview

Journal Tumour Biol

Publisher Sage Publications

Specialty Oncology

Date 2014 Jun 28

PMID 24969563

Citations 45

Authors

Dimitry A Chistiakov

Vladimir P Chekhonin

Affiliations

Soon will be listed here.

Abstract

Extracellular vesicles (EVs) are commonly used by normal and tumor cells for communication at long distances to exchange by complex molecular messages and deliver a variety of essential biomolecules. EVs (exosomes and microvesicles) released in large numbers by glioma cells represent a key mechanism of intercellular signaling. Tumor-derived EVs are produced to regulate all vital functions of tumor cells including growth, proliferation, migration, survival, malignancy, invasion, and resistance to host anti-tumor immunity and anti-cancer drugs. Glioma EVs were shown to carry a variety of biomolecules such as oncogenic growth factors, receptors, enzymes, transcription factors, signaling and immunomodulatory molecules, DNA of mutated and nonmutated oncogenes, RNA transcripts, and noncoding RNA including retrotransposons, vault RNA, and microRNAs. Glioma-derived EVs can be useful as a source of potential tumor-associated biomarkers essential for development and validation of new diagnostic and prognostic tools for glioma and glioblastoma. Tumor EVs are enriched with glioma antigens that could be helpful, for example, for development of new advanced anti-tumor immune vaccines based on autologous dendritic cells stimulated by tumor-specific antigens.

Citing Articles

Unlocking the therapeutic potential of tumor-derived EVs in ischemia-reperfusion: a breakthrough perspective from glioma and stroke.

Hao Z, Guan W, Wei W, Li M, Xiao Z, Sun Q J Neuroinflammation. 2025; 22(1):84.

PMID: 40089793 DOI: 10.1186/s12974-025-03405-7.

Exploring the clinical implications and applications of exosomal miRNAs in gliomas: a comprehensive study.

Yang L, Niu Z, Ma Z, Wu X, Vong C, Li G Cancer Cell Int. 2024; 24(1):323.

PMID: 39334350 PMC: 11437892. DOI: 10.1186/s12935-024-03507-x.

Overcoming Resistance to Temozolomide in Glioblastoma: A Scoping Review of Preclinical and Clinical Data.

Smerdi D, Moutafi M, Kotsantis I, Stavrinou L, Psyrri A Life (Basel). 2024; 14(6).

PMID: 38929657 PMC: 11204771. DOI: 10.3390/life14060673.

The Inhibition of the FGFR/PI3K/Akt Axis by AZD4547 Disrupts the Proangiogenic Microenvironment and Vasculogenic Mimicry Arising from the Interplay between Endothelial and Triple-Negative Breast Cancer Cells.

Morales-Guadarrama G, Mendez-Perez E, Garcia-Quiroz J, Avila E, Ibarra-Sanchez M, Esparza-Lopez J Int J Mol Sci. 2023; 24(18).

PMID: 37762073 PMC: 10531243. DOI: 10.3390/ijms241813770.

Exosomes as Novel Diagnostic Biomarkers and Therapeutic Tools in Gliomas.

Skouras P, Gargalionis A, Piperi C Int J Mol Sci. 2023; 24(12).

PMID: 37373314 PMC: 10299187. DOI: 10.3390/ijms241210162.

References

Liu Z, Wang Y, Yuan X . Exosomes from murine-derived GL26 cells promote glioblastoma tumor growth by reducing number and function of CD8+T cells. Asian Pac J Cancer Prev. 2013; 14(1):309-14. DOI: 10.7314/apjcp.2013.14.1.309. View

Skog J, Wurdinger T, van Rijn S, Meijer D, Gainche L, Sena-Esteves M . Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol. 2008; 10(12):1470-6. PMC: 3423894. DOI: 10.1038/ncb1800. View

Arscott W, Tandle A, Zhao S, Shabason J, Gordon I, Schlaff C . Ionizing radiation and glioblastoma exosomes: implications in tumor biology and cell migration. Transl Oncol. 2014; 6(6):638-48. PMC: 3890698. DOI: 10.1593/tlo.13640. View

Kim W, Liau L . Dendritic cell vaccines for brain tumors. Neurosurg Clin N Am. 2009; 21(1):139-57. PMC: 2810429. DOI: 10.1016/j.nec.2009.09.005. View

Hanson P, Cashikar A . Multivesicular body morphogenesis. Annu Rev Cell Dev Biol. 2012; 28:337-62. DOI: 10.1146/annurev-cellbio-092910-154152. View

Malek S, Dordai D, Reim J, DINTZIS H, Desiderio S . Malignant transformation of early lymphoid progenitors in mice expressing an activated Blk tyrosine kinase. Proc Natl Acad Sci U S A. 1998; 95(13):7351-6. PMC: 22613. DOI: 10.1073/pnas.95.13.7351. View

Yang C, Wang C, Chen X, Chen S, Zhang Y, Zhi F . Identification of seven serum microRNAs from a genome-wide serum microRNA expression profile as potential noninvasive biomarkers for malignant astrocytomas. Int J Cancer. 2012; 132(1):116-27. DOI: 10.1002/ijc.27657. View

Davis D, Sowinski S . Membrane nanotubes: dynamic long-distance connections between animal cells. Nat Rev Mol Cell Biol. 2008; 9(6):431-6. DOI: 10.1038/nrm2399. View

Forseen S, Potti A, Koka V, Koch M, Fraiman G, Levitt R . Identification and relationship of HER-2/neu overexpression to short-term mortality in primary malignant brain tumors. Anticancer Res. 2002; 22(3):1599-602. View

10.

Nduom E, Yang C, Merrill M, Zhuang Z, Lonser R . Characterization of the blood-brain barrier of metastatic and primary malignant neoplasms. J Neurosurg. 2013; 119(2):427-33. PMC: 4746720. DOI: 10.3171/2013.3.JNS122226. View

11.

Noerholm M, Balaj L, Limperg T, Salehi A, Zhu L, Hochberg F . RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls. BMC Cancer. 2012; 12:22. PMC: 3329625. DOI: 10.1186/1471-2407-12-22. View

12.

Bienkowski M, Piaskowski S, Stoczynska-Fidelus E, Szybka M, Banaszczyk M, Witusik-Perkowska M . Screening for EGFR amplifications with a novel method and their significance for the outcome of glioblastoma patients. PLoS One. 2013; 8(6):e65444. PMC: 3675194. DOI: 10.1371/journal.pone.0065444. View

13.

Bu N, Wu H, Sun B, Zhang G, Zhan S, Zhang R . Exosome-loaded dendritic cells elicit tumor-specific CD8+ cytotoxic T cells in patients with glioma. J Neurooncol. 2011; 104(3):659-67. DOI: 10.1007/s11060-011-0537-1. View

14.

Mohanan V, Temburni M, Kappes J, Galileo D . L1CAM stimulates glioma cell motility and proliferation through the fibroblast growth factor receptor. Clin Exp Metastasis. 2012; 30(4):507-20. DOI: 10.1007/s10585-012-9555-4. View

15.

DAgostino S, Salamone M, Di Liegro I, Vittorelli M . Membrane vesicles shed by oligodendroglioma cells induce neuronal apoptosis. Int J Oncol. 2006; 29(5):1075-85. View

16.

Booth A, Fang Y, Fallon J, Yang J, Hildreth J, Gould S . Exosomes and HIV Gag bud from endosome-like domains of the T cell plasma membrane. J Cell Biol. 2006; 172(6):923-35. PMC: 2063735. DOI: 10.1083/jcb.200508014. View

17.

Krejsgaard T, Vetter-Kauczok C, Woetmann A, Kneitz H, Eriksen K, Lovato P . Ectopic expression of B-lymphoid kinase in cutaneous T-cell lymphoma. Blood. 2009; 113(23):5896-904. PMC: 2700325. DOI: 10.1182/blood-2008-09-181024. View

18.

Gast D, Riedle S, Kiefel H, Muerkoster S, Schafer H, Schafer M . The RGD integrin binding site in human L1-CAM is important for nuclear signaling. Exp Cell Res. 2008; 314(13):2411-8. DOI: 10.1016/j.yexcr.2008.04.004. View

19.

Godlewski J, Nowicki M, Bronisz A, Nuovo G, Palatini J, De Lay M . MicroRNA-451 regulates LKB1/AMPK signaling and allows adaptation to metabolic stress in glioma cells. Mol Cell. 2010; 37(5):620-32. PMC: 3125113. DOI: 10.1016/j.molcel.2010.02.018. View

20.

von Bartheld C, Altick A . Multivesicular bodies in neurons: distribution, protein content, and trafficking functions. Prog Neurobiol. 2011; 93(3):313-40. PMC: 3055956. DOI: 10.1016/j.pneurobio.2011.01.003. View